Showing papers in "Journal of Vascular Surgery in 2011"

TL;DR: The Society for Vascular Surgery and the American Venous Forum have developed clinical practice guidelines for the care of patients with varicose veins of the lower limbs and pelvis, including recommendations on the management of superficial and perforating vein incompetence in patients with associated, more advanced chronic venous diseases.

TL;DR: Recommendations are made using the GRADE (Grades of Recommendation Assessment, Development and Evaluation) system, as has been done with other Society for Vascular Surgery guideline documents.[corrected] the perioperative risk of stroke and death in asymptomatic patients must be <3% to ensure benefit for the patient.

TL;DR: It is suggested that endovascular repair of thoracic aortic transection is associated with better survival and decreased risk of spinal cord ischemia, renal injury, graft, and systemic infections compared with open repair or nonoperative management.

TL;DR: In patients with low to intermediate risk factors, open repair of AAA is as safe as EVAR and remains a more durable option.

TL;DR: Core muscle size, an objective measure of frailty, correlates strongly with mortality after elective AAA repair and may aid in risk stratification and impact timing of surgical repair, especially in more complex aortic operations.

TL;DR: Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach, which reduces complications and improves outcomes.

TL;DR: Fibromuscular dysplasia should be considered in the differential diagnosis of a young person with a cervical bruit; a "swishing" sound in the ear(s); transient ischemic attack, stroke, or dissection of an artery; or in individuals aged ≤ 35 years with onset hypertension.

TL;DR: The review was done using the GRADE methodology and found that asymptomatic patients at high risk for intervention or with <3 years life expectancy should be considered for medical management as first line therapy.

TL;DR: COBEST demonstrates covered and bare-metal stents produce similar and acceptable results for TASC B lesions, however, covered stents perform better for Tasc C and D lesions than bare stents in longer-term patency and clinical outcome.

TL;DR: Spinal cord ischemia after TEVAR is an uncommon, but important complication, and preoperative renal insufficiency was identified as a risk factor for the development of SCI.

TL;DR: Ch-EVAR appears to have similar mortality to open repair with less morbidity, and may extend the anatomical eligibility of endovascular aneurysm repair using conventional devices.

TL;DR: PTA has altered the treatment paradigm for lower limb ischemia with an increase in costs and procedures, and although mortality is slightly lower with PTA for all indications, amputation rates for limb-threat patients appear higher, as does the average cost.

TL;DR: Intraoperative use utilizing fusion imaging limits contrast dosage and postdeployment CBCT is of sufficient quality to evaluate successful aneurysm exclusion and for detection of early complications after FEVAR.

TL;DR: In this multicenter observational study, compliance with EVAR device guidelines was low and post-EVAR aneurysm sac enlargement was high, raising concern for long-term risk of aneurYSm rupture.

TL;DR: Isolated lower extremity trauma with vascular injury has a nearly 10% rate of mortality or limb loss and Mortality is associated with penetrating mechanism and early shock, likely resulting from prehospital proximal arterial hemorrhage.

TL;DR: CG is feasible and efficient to treat JAA in patients unsuitable for FBE, and until the anatomic applicability of FBE is extended and off-the-shelf FBE devices are available, CG remains a feasible endovascular option for high-risk JAA patients.

TL;DR: Although the long-term outcome after open repair for elective AAA was also worse for women, EVAR benefit for women was sustained longer than for men, and specific risk factors that would be potential targets for improving AAA management need to be isolated.

TL;DR: Women are significantly less likely to meet device IFU criterion for EVAR, and devices that accommodate shorter infrarenal AAA neck length will have the greatest impact on expanding on-label EVAR regardless of gender.

TL;DR: The use of good fluoroscopic technique is imperative for physician and patient protection, and several key maneuvers can help decrease exposure for both the patient and the physician.

TL;DR: The incidence of endograft infection is below 1%, with a mortality rate of 25%.

TL;DR: Clinical benefits were reported from these trials including improvement of ankle-brachial index, transcutaneous partial pressure of oxygen, reduction of pain, and decreased need for amputation, but large randomized, placebo-controlled, double-blind studies are necessary and currently ongoing to provide stronger safety and efficacy data on cell therapy.

TL;DR: Compared with endarterectomy, carotid artery stenting (CAS) significantly increases the risk of any stroke and decreases therisk of MI.

TL;DR: SSI is a common complication after open revascularization and is associated with a more than twofold increased risk of early graft loss and reoperation, suggesting that targeted improvements in perioperative care may decrease complications and improve outcomes in this patient population.

TL;DR: Emergency TEVAR for patients with cTBAoD (malperfusion or rupture) provided acceptable mortality and morbidity results out to 1 year, and manufacturers can use this 30-day mortality point-estimate for the acute cohort to establish a performance goal for use in single-arm commercial IDE trials if the Food and Drug Administration and other regulatory bodies concur.

TL;DR: The everolimus-eluting self-expanding nitinol stent can be successfully implanted in patients with severe peripheral arterial disease with favorable outcomes and clinical improvements observed in the majority of patients.

TL;DR: The findings suggest that both tumor type and resection magnitude may impact VTE risk and support diagnosis and procedural-specific guidelines for perioperative VTE prophylaxis and can be used to anticipate the risk of potentially preventable morbidity.

TL;DR: The results of the Durability-200 study show an acceptable primary patency rate after 1 year was obtained in this patient cohort with TASC C and D femoropopliteal lesions.

TL;DR: RAAD is a lethal early complication of TEVAR, which may be more common when treating dissection, with devices utilizing proximal bare springs or barbs for fixation, with native zone 0 proximal landing zone and with ascending aortic diameter ≥ 4 cm.

TL;DR: The current multidisciplinary team management approach, including use of computed tomographic or conventional angiography and prompt surgical management, resulted in successful outcomes after lower extremity arterial injuries and will continue to be utilized.